『Multisystem Immune-Related Adverse Events Associated With ImmuneCheckpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer』（JAMA Oncol 2020, Published Oct. 29）より まとめ 免疫関連有害事象を認めた群が有害事象がなかった群に比べて…